Schwartz TW - Search Results

1

Metal-ion sites as structural and functional probes of helix-helix interactions in 7TM receptors.

Elling CE, Thirstrup K, Nielsen SM, Hjorth SA, Schwartz TW. Elling CE, et al. Among authors: schwartz tw. Ann N Y Acad Sci. 1997 Apr 24;814:142-51. doi: 10.1111/j.1749-6632.1997.tb46152.x. Ann N Y Acad Sci. 1997. PMID: 9160966 Review. No abstract available.

2

Signal epitopes in the three-dimensional structure of neuropeptide Y. Interaction with Y1, Y2, and pancreatic polypeptide receptors.

Schwartz TW, Fuhlendorff J, Kjems LL, Kristensen MS, Vervelde M, O'Hare M, Krstenansky JL, Bjørnholm B. Schwartz TW, et al. Ann N Y Acad Sci. 1990;611:35-47. doi: 10.1111/j.1749-6632.1990.tb48920.x. Ann N Y Acad Sci. 1990. PMID: 2174222 No abstract available.

3

Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding.

Rosenkilde MM, Cahir M, Gether U, Hjorth SA, Schwartz TW. Rosenkilde MM, et al. Among authors: schwartz tw. J Biol Chem. 1994 Nov 11;269(45):28160-4. J Biol Chem. 1994. PMID: 7525569 Free article.

4

Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes.

Hjorth SA, Adelhorst K, Pedersen BB, Kirk O, Schwartz TW. Hjorth SA, et al. Among authors: schwartz tw. J Biol Chem. 1994 Dec 2;269(48):30121-4. J Biol Chem. 1994. PMID: 7527026 Free article.

5

Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor.

Elling CE, Nielsen SM, Schwartz TW. Elling CE, et al. Among authors: schwartz tw. Nature. 1995 Mar 2;374(6517):74-7. doi: 10.1038/374074a0. Nature. 1995. PMID: 7532789

6

Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.

Hjorth SA, Thirstrup K, Grandy DK, Schwartz TW. Hjorth SA, et al. Among authors: schwartz tw. Mol Pharmacol. 1995 Jun;47(6):1089-94. Mol Pharmacol. 1995. PMID: 7541509

7

Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.

Gether U, Yokota Y, Emonds-Alt X, Brelière JC, Lowe JA 3rd, Snider RM, Nakanishi S, Schwartz TW. Gether U, et al. Among authors: schwartz tw. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6194-8. doi: 10.1073/pnas.90.13.6194. Proc Natl Acad Sci U S A. 1993. PMID: 7687062 Free PMC article.

8

Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor.

Schambye HT, Hjorth SA, Weinstock J, Schwartz TW. Schambye HT, et al. Among authors: schwartz tw. Mol Pharmacol. 1995 Mar;47(3):425-31. Mol Pharmacol. 1995. PMID: 7700239

9

Locating ligand-binding sites in 7TM receptors by protein engineering.

Schwartz TW. Schwartz TW. Curr Opin Biotechnol. 1994 Aug;5(4):434-44. doi: 10.1016/0958-1669(94)90054-x. Curr Opin Biotechnol. 1994. PMID: 7765177 Review.

10

Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.

Perlman S, Schambye HT, Rivero RA, Greenlee WJ, Hjorth SA, Schwartz TW. Perlman S, et al. Among authors: schwartz tw. J Biol Chem. 1995 Jan 27;270(4):1493-6. doi: 10.1074/jbc.270.4.1493. J Biol Chem. 1995. PMID: 7829475 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters